期刊文献+

核黄素光化学技术灭活血浆病原体的研究进展 被引量:2

下载PDF
导出
摘要 亚甲蓝光化学法等常用的病毒灭活技术在血浆中的应用,可有效降低经血传播病毒的风险。然而,血液的安全输注依旧会受到一些对目前常用的病毒灭活方法欠敏感及潜在或未知病毒的威胁,因此,新的、更有效的病毒灭活技术有待开发和应用。核黄素光化学法就是一种灭活血浆病毒的新方法,具有着灭活病毒谱广、灭活效果好、安全可靠以及经处理后血浆中蛋白质稳定性高等优点。本文就核黄素光化学技术灭活血浆病毒的现状和相关研究进行综述。
出处 《临床输血与检验》 CAS 2013年第4期403-406,共4页 Journal of Clinical Transfusion and Laboratory Medicine
基金 军队重大专项课题资助项目(AWS11J007-08)资助
  • 相关文献

参考文献24

  • 1D Teo,S Lain. Pathogen inactivation[J]. ISBT Science Series, 2011,6 (2) : 6,449-453.
  • 2Wu CG,MB,Jong J,et al. Parvovirus B19 transmission by a high-purity factor W concentrate[J] Transfu- sion, 2005,45 (6) : 1003-1010.
  • 3Seghatchian J ,Walker WH,Reichenberg S. Updates on pathogen inactivation of plasma using Theraflex methy- lene blue system[J]. Transfus Apher Sci,2008,38(3) : 271-280.
  • 4Moog R, Reichenberg S,Hoburg A,et al. Quality of methylene blue-treated fresh-frozen plasma stored up to 27 months 9letter[J]. Transfusion, 2010, 50 (2): 516-518.
  • 5Suontaka AM,Blomback M,Chapman J. Changes in functional activities of plasma fibrinogen after treat- ment with methylene blue and red light [J]. Transfu- sion, 2003,43 (5) : 568-575.
  • 6Roc G. A comparison of methods of pathogen inactiva- tion of FFP[J]. Vox Sanguinis ,2011,100(2) :169-178.
  • 7Petteys BJ,Frank EL. Rapid determination of vitamin B2 (riboflavin) in plasma by HPLC[J]. Cliniea Chimiea Acta, 412 (1-2) : 38-43.
  • 8Marschner S,Goodrich R. Pathogen Reduction Tech- nology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light [J]. Transfus Med Hemother, 2011,88-118.
  • 9Thomas H. Muller,Thomas Montag,Axei W. Labora- tory evaluation of the effetiveness of pathogen reduc- tion procedures for bacteria[J] Transfus Med Hemother, 2011,38 (4) : 242-250.
  • 10Raymond PG,Suzann D, et al. Design and develop- ment of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products [J]. Biologicals, 2010,38 (1) : 20-30.

同被引文献30

  • 1嵇月红,田兆嵩.静脉用免疫球蛋白临床应用的副作用[J].中国输血杂志,2005,18(1):77-81. 被引量:11
  • 2Fast I.D, I)ileone G, Marschner S. Inactivation of human white blood cells in platelet products after pathogen reduction technolo gy treatment in comparison to gamma irradiation[J]. Transfu- sion,2011,51(7) :1397-1404.
  • 3Cazenave JP, Isola H, Waller C, et al. Use of additive solutions and pathogen inactivation treammnt of platelet components in a re- gional blood center:impact on patient outcomes and component u- tilization during a 3 year period[J]. Transfusion, 2011,51 (3): 622-629.
  • 4Goodrich RP, Gilmour D, Hovenga N, et al. A laboratory compari- son of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns [J]. Transfusion,2009,49(6) : 1205 1216.
  • 5Marschner S, Goodrich R. Pathogen reduction technology treat- ment of platelets, plasma and whole blood using riboflavin and UV light[J]. Transfus Med Hemother,2011,38(1) :8-18.
  • 6Irsch J,Lin I.. Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT blood sys- tem? [J].Transfus Med Hemother,2011,38(1):19-31.
  • 7Seltsam A, Mailer TH. UVC irradiation for pathogen reduction of platelet concentrates and plasma[J].Transfus Med Hemother, 2011,38(1) :43-54.
  • 8Mohr H,Steil L,Gravemann U,et al. A novel approach to patho gen reduction in platelet concentrates using short wave ultraviolet light[J]. Transfusion, 2009,49 (12) : 2612 -2624.
  • 9Henschler R, Seifried E, Mufti N. Development of the S-303pathogen inactivation technology for red blood cell concentrates[J].Transfos Med Hemother,2011,38(1) :33-42.
  • 10Mufti NA, Erickson AC, North AK, et al. Treatment of whole blood (WB) and red blood cells (RBC) with S 303 inactivates pathogens and retains in vitro quality of stored RBC[J]. Biologi- cals,2010,38(1):14 19.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部